Egyptian Folk Traditions Take Centre Stage at Alamein Iconic Performances Celebrate Egyptian and Palestinian Heritage Opera Al Layla Al-Kabira and Reda Troupe Steal the Show …
Solar District Cooling Group Berhad Signs Underwriting Agreement with Mercury Securities Sdn Bhd for Its IPO on the ACE Market of Bursa Malaysia Securities Berhad
KUALA LUMPUR, Aug 14, 2024 – (ACN Newswire via SeaPRwire.com) – Solar District Cooling Group Berhad (“SDCG”) is pleased to announce that it has entered …
新能源助推绿色转型 中国港能打造智慧能源新蓝图
香港, 2024年8月14日 – (亚太商讯 via SeaPRwire.com) – 中国港能智慧能源集团有限公司(股份代号:0931.HK,以下简称“中国港能”)在香港成功召开2024年度业绩投资者交流会。本次活动是自中国港…
Kincora and AngloGold Ashanti’s First Drilling Program
The first ever copper-gold focused drilling program at the northern portion of the Nyngan Project will shortly commence with earn-in partner AngloGold Ashanti Australia (AngloGold …
Experience Eternal Romance with Exquisite Blue Diamonds by ALUXE
SINGAPORE, Aug 14, 2024 – (ACN Newswire via SeaPRwire.com) – ALUXE, cherished for its unwavering commitment to celebrating love and happiness, is delighted to introduce 8 …
Nissin Foods Becomes a Constituent of MSCI Global Micro Cap Index (MSCI Hong Kong Index)
HONG KONG, Aug 14, 2024 – (ACN Newswire via SeaPRwire.com) – Nissin Foods Company Limited (“Nissin Foods” or the “Company”, together with its subsidiaries, the …
日清食品为MSCI全球微型股指数(MSCI香港指数)成份股之一
香港, 2024年8月14日 – (亚太商讯 via SeaPRwire.com) – 日清食品有限公司(「日清食品」或「公司」,连同其附属公司统称「集团」;股份代号:1475)欣然宣布集团已获纳入MSCI全球微型股指数(MSC…
Modern DevOps Melbourne 2024 Partners with ACN Newswire; Offers Exclusive Discount
MELBOURNE, Aug 14, 2024 – (ACN Newswire via SeaPRwire.com) – Mark your calendars for an unmissable event! We are thrilled to announce our partnership with …
Experience Eternal Romance with Exquisite Blue Diamonds
SINGAPORE, Aug 14, 2024 – (ACN Newswire via SeaPRwire.com) – ALUXE, cherished for its unwavering commitment to celebrating love and happiness, is delighted to introduce 8 …
Sino Biopharmaceutical (1177.HK) Announces 2024 Interim Results
Development Highlights – During the reporting Period, four of the Group’s innovative products were approved for marketing by the National Medical Products Administration of China …
中国生物制药(1177.HK)公布2024中期业绩
重点成果 – 期内,集团共有4个创新产品获中国国家药品监督管理局(「NMPA」)批准上市,分别为安得卫(贝莫苏拜单抗注射液)、安柏尼(富马酸安奈克替尼胶囊)、安洛晴(枸橼酸依奉阿克胶囊)和贝乐林(利拉鲁肽注射液),其中3个为国家…











